Dienogest versus gonadotropin-releasing hormone analogues for the clinical treatment of endometriosis: an updated meta-analysis

Simple item page
dc.contributor.authorMajeed, Ken_US
dc.contributor.authorHanif, ZMen_US
dc.contributor.authorMurtaza, Men_US
dc.contributor.authorAli, Hen_US
dc.contributor.authorBatool, Aen_US
dc.contributor.authorSyed, H.en_US
dc.date.accessioned2025-05-12T08:25:52Z
dc.date.available2025-05-12T08:25:52Z
dc.date.issued2024-12
dc.description.abstractEndometriosis is a chronic gynecological condition where endometrial-like tissue grows outside the uterus, leading to persistent pelvic pain, dysmenorrhea, dyspareunia, and infertility. The objective of the systematic review was to examine the efficacy and safety of Dienogest, which is a synthetic, orally active 19-nortestosterone derivative, in the treatment of women with endometriosis compared to GnRH-a, which is commonly used to treat conditions like endometriosis. We conducted a search of PubMed, Google Scholar, and Cochrane Library databases from inception until August 2024 for clinical studies, using the following keywords: ("Dienogest") and ("gonadotropin-releasing hormone analogue" or GnRH Analogues OR GnRH agonist) and (Endometriosis). Relevant randomized control trials were identified. Pooled effect estimates were calculated using a random effect model. This meta-analysis included eight randomized controlled trials (RCTs) with 1,219 patients, 602 in the dienogest group and 617 in the GnRH analogue group. Both treatments were equally effective in controlling pain, dysmenorrhea, and dyspareunia, but dienogest offered advantages. Dienogest significantly reduced the recurrence rate (RR: 0.37, 95% CI [0.15, 0.91]; p=0.03) and hot flushes (RR: 0.24, 95% CI [0.10, 0.59]; p=0.002) and protected against bone mineral density (BMD) loss. However, it increased the risk of irregular vaginal bleeding (RR: 3.61, 95% CI [1.09, 11.97]; p=0.04). Other side effects, such as headache, vaginal dryness, spotting, and alopecia, were not statistically significant. It concluded that Dienogest has comparatively fewer side effects than GnRH analogue, making it a considerably safer option for treating endometriosis.en_US
dc.identifier.affiliationsDepartment of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistanen_US
dc.identifier.affiliationsDepartment of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistanen_US
dc.identifier.affiliationsDepartment of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistanen_US
dc.identifier.affiliationsDepartment of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistanen_US
dc.identifier.affiliationsDepartment of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistanen_US
dc.identifier.affiliationsDepartment of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistanen_US
dc.identifier.citationMajeed K, Hanif ZM, Murtaza M, Ali H, Batool A, Syed H.. Dienogest versus gonadotropin-releasing hormone analogues for the clinical treatment of endometriosis: an updated meta-analysis . International Journal of Scientific Reports. 2024 Dec; 10(12): 432-441en_US
dc.identifier.issn2454-2156
dc.identifier.issn2454-2164
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/246981
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber12en_US
dc.relation.volume10en_US
dc.source.urihttps://doi.org/10.18203/issn.2454-2156.IntJSciRep20243494en_US
dc.subjectDienogesten_US
dc.subjectGnRH analogueen_US
dc.subjectGnRH agonist and endometriosisen_US
dc.titleDienogest versus gonadotropin-releasing hormone analogues for the clinical treatment of endometriosis: an updated meta-analysisen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijsr2024v10n12p432.pdf
Size:
600.2 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Scientific Reports